LV11026A - Farmaceitiska kompozicija asinsspiediena pazeminasanai un tas iegusanas panemiens - Google Patents

Farmaceitiska kompozicija asinsspiediena pazeminasanai un tas iegusanas panemiens

Info

Publication number
LV11026A
LV11026A LV950225A LV950225A LV11026A LV 11026 A LV11026 A LV 11026A LV 950225 A LV950225 A LV 950225A LV 950225 A LV950225 A LV 950225A LV 11026 A LV11026 A LV 11026A
Authority
LV
Latvia
Prior art keywords
retarding
pharmaceutical composition
blood pressure
lowering blood
lowering
Prior art date
Application number
LV950225A
Other languages
English (en)
Other versions
LV11026B (en
Inventor
Margit Nagy
Csaba Farsang
Lidia Fedina
Katalin Szemeredi
Gabor Szenasi
Janos Egri
Antal Mosonyi
Borbala Barta
Gizella Toth
Ibolya Nyaradi
Frigyes Gorenyi
Zsuzsa Orr
Geza Floris
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of LV11026A publication Critical patent/LV11026A/lv
Publication of LV11026B publication Critical patent/LV11026B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LVP-95-225A 1994-07-26 1995-07-25 A pharmaceutical composition for lowering the blood pressure and a process for the preparation thereof LV11026B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9402193A HU214582B (hu) 1994-07-26 1994-07-26 Porlasztható, vérnyomáscsökkentő hatású gyógyszerkészítmény és eljárás előállítására

Publications (2)

Publication Number Publication Date
LV11026A true LV11026A (lv) 1996-02-20
LV11026B LV11026B (en) 1996-04-20

Family

ID=10985460

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-95-225A LV11026B (en) 1994-07-26 1995-07-25 A pharmaceutical composition for lowering the blood pressure and a process for the preparation thereof

Country Status (18)

Country Link
JP (1) JPH08169829A (lv)
AT (1) AT402690B (lv)
AU (1) AU699386B2 (lv)
BE (1) BE1011413A4 (lv)
CZ (1) CZ286399B6 (lv)
DE (1) DE19527140A1 (lv)
EE (1) EE9500029A (lv)
FR (1) FR2722988B1 (lv)
GB (1) GB2291593B (lv)
HR (1) HRP950374A2 (lv)
HU (1) HU214582B (lv)
IT (1) IT1277348B1 (lv)
LT (1) LT4042B (lv)
LV (1) LV11026B (lv)
PL (1) PL181069B1 (lv)
SK (1) SK280463B6 (lv)
UA (1) UA39880C2 (lv)
YU (1) YU50795A (lv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030095925A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
EP2042161A1 (en) * 1997-10-01 2009-04-01 Novadel Pharma Inc. Propellant-free spray composition comprising anti-emetic agent
US7632517B2 (en) 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
US8097614B2 (en) * 2005-02-17 2012-01-17 Velcera Pharmaceuticals, Inc. Transmucosal administration of meloxicam compositions for treating and preventing disorders in non-human domesticated animals
DE102006027794A1 (de) * 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag Antihypertonie-Kombinationswafer
FR2906140B1 (fr) * 2006-09-22 2008-12-05 Philippe Perovitch Forme galenique pour l'administration par voie trans-muqueuse de principes actifs

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3307422A1 (de) * 1983-03-03 1984-09-06 Bayer Ag, 5090 Leverkusen Fluessigzubereitungen von dihydropyridinen, ein verfahren zu ihrer herstellung, sowie ihre verwendung bei der bekaempfung von erkrankungen
EP0175671A1 (de) 1984-08-23 1986-03-26 Kuhlemann & Co. Pharmazeutische Zubereitung sowie Verfahren zum Darreichen dieser pharmazeutischen Zubereitung
DE3544692A1 (de) * 1985-12-18 1987-06-19 Bayer Ag Dihydropyridinspray, verfahren zu seiner herstellung und seine pharmazeutische verwendung
ES2038696T3 (es) * 1986-03-10 1996-07-16 Burghart Kurt Procedimiento para producir un preparado farmaceutico.
US4863970A (en) * 1986-11-14 1989-09-05 Theratech, Inc. Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols
DE3779999T2 (de) * 1986-11-14 1992-12-10 Theratech Inc Erhoehung des penetrationsvermoegens mittels eines aus die zellhuelle veraendernden substanzen und kurzkettigen alkoholen bestehenden binaeren systems.
JPS63170316A (ja) * 1986-12-30 1988-07-14 Fujimoto Seiyaku Kk ニフエジピン経皮吸収外用製剤
DE3714402A1 (de) * 1987-04-30 1988-11-10 Kali Chemie Pharma Gmbh Arzneimittelformulierung
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
AT391269B (de) * 1988-12-30 1990-09-10 Burghart Kurt Pharmazeutische zubereitung
US5298258A (en) * 1989-12-28 1994-03-29 Nitto Denko Corporation Acrylic oily gel bioadhesive material and acrylic oily gel preparation
HU205249B (en) * 1990-11-09 1992-04-28 Egyt Gyogyszervegyeszeti Gyar Process for producing suspensive aerosole composition

Also Published As

Publication number Publication date
ITMI951621A1 (it) 1997-01-26
AT402690B (de) 1997-07-25
SK280463B6 (sk) 2000-02-14
AU2326995A (en) 1996-02-08
HUT75457A (en) 1997-05-28
JPH08169829A (ja) 1996-07-02
GB2291593B (en) 1998-03-11
BE1011413A4 (fr) 1999-09-07
YU50795A (sh) 1998-05-15
ATA121495A (de) 1996-12-15
FR2722988B1 (fr) 1999-10-08
DE19527140A1 (de) 1996-02-01
SK92295A3 (en) 1996-05-08
HU214582B (hu) 1998-04-28
GB2291593A (en) 1996-01-31
HRP950374A2 (en) 1997-10-31
ITMI951621A0 (it) 1995-07-26
PL309757A1 (en) 1996-02-05
LT95084A (en) 1996-06-25
HU9402193D0 (en) 1994-09-28
LT4042B (en) 1996-09-25
CZ286399B6 (en) 2000-04-12
CZ181195A3 (en) 1996-02-14
PL181069B1 (pl) 2001-05-31
UA39880C2 (uk) 2001-07-16
AU699386B2 (en) 1998-12-03
GB9515205D0 (en) 1995-09-20
LV11026B (en) 1996-04-20
IT1277348B1 (it) 1997-11-10
EE9500029A (et) 1996-02-15
FR2722988A1 (fr) 1996-02-02

Similar Documents

Publication Publication Date Title
DE69513671D1 (de) Arzneimittel
DE69529598T2 (de) Arzneimittelenthaltende Manschette
KR950703566A (ko) 티에노디아제핀 화합물 및 그의 의약 용도[thienodiazepine compound and medicinal use thereof]
FI973243A (fi) Uusi farmaseuttinen yhdistelmä
NO965343L (no) For inneholdende naturlegemiddel
KR960700239A (ko) 크로만 유도체 및 그의 제약학적 용도(chroman derivative and medicinal use thereof)
HU9503835D0 (en) Soft gelatin pharmaceutical dosage form
DE69524592D1 (de) 2-Acylaminopropanolverbindung und ihre pharmazeutische Zusammensetzung
BR9610214A (pt) Compostos farmacéuticos
LV10386A (lv) Farmaceitiska kompozicija un tas pagatavosanas panemiens
BR9509688A (pt) Composto e composição farmacêutica
BR9507768A (pt) Composição farmacêutica
LV11026A (lv) Farmaceitiska kompozicija asinsspiediena pazeminasanai un tas iegusanas panemiens
FI951155A0 (fi) Farmaseuttinen valmiste
NO965448D0 (no) Farmasöytiske forbindelser
KR950022649U (ko) 약탕기
BR9505130A (pt) Composto e composiçao farmacêutica
KR950026742U (ko) 혈액역류 방지장치
UA666S (uk) Таблетка істивна, зокрема фармацевтична
SE9402432D0 (sv) New pharmaceutical dosage form
KR950025254U (ko) 창문용 크레센트정
NO962816D0 (no) Farmasöytiske forbindelser
SE9401674L (sv) Läkemedel
NO944330D0 (no) Legemiddel
SE9402131D0 (sv) Läkemedel